The 4th Multidisciplinary Lung Cancer Conference
Date: 1st – 2nd March 2019
Venue: Mandarin Orchard Singapore
Day 1: Friday, 1 March 2019
| Time | Programme | Speaker/Chairpersons |
|---|---|---|
| 0800 – 0900 | Registration / Coffee | |
| 0900 – 0905 | Welcome Address | Toh Chee Keong |
| 0905 – 0910 | Introduction to 4th Multidisciplinary Lung Cancer Conference | Ross Soo |
| 0910 – 0950 | Keynote address: The Era of Translational Research | Raphael Bueno |
| 0950 – 1110 | Session 1: Lung Cancer Screening | Chairpersons: Cheah Foong Koon Ong Boon Hean |
| 0950 – 1010 | Lung Cancer Screening | Charlene Liew |
| 1010 – 1030 | Management of Indeterminate Pulmonary Nodule | Anantham Devanand |
| 1030 – 1050 | Current Directions for Screening in Singapore | Toh Chee Keong |
| 1050 – 1110 | Imaging: Role of AI for Early Detection | Zeng Zeng |
| 1110 – 1200 | Morning Tea Symposium (sponsored by Takeda) | |
| 1200 – 1320 | Session 2: Pathology | Chairpersons: Tan Soo Yong Tan Yew Oo |
| 1200 – 1220 | Molecular Testing for NSCLC 2019 | Ming Tsao |
| 1220 – 1240 | Incorporating Emerging Technologies Into The Clinic (Liquid Biopsies, NGS) (sponsored by BMS) | Tony Mok |
| 1240 – 1300 | Value Driven Health Care in Cancer | Ng Kwong Hoe |
| 1300 – 1320 | Panel Discussion / Voting Next Generation Sequencing: Ready for Prime Time? |
Brendan Pang, Brett Doble, Daniel Tan, Ming Tsao, Tan Soo Yang, Tan Yew Oo, Tony Mok |
| 1320 – 1420 | Lunch Symposium (sponsored by Boehringer Ingelheim) | |
| 1320 – 1420 | Treatment Strategy with EGFR TKIs: A Marathon or Sprint? | Tony Mok |
| 1420 – 1520 | Session 3: Early Stage Disease | Chairpersons: Atasha Binti Asmat Phua Ghee Chee |
| 1420 – 1440 | Role of Minimally Invasive Techniques (Robotics / VATS) and Sublobar Resections for Early Stage Lung Cancer | Dokev Basheer Ahmed Aneez Ahmed |
| 1440 – 1500 | Radiation: SBRT, Radical RT | Anuradha Thiagarajan |
| 1500 – 1520 | Bronchoscopic Approaches to Early Stage Lung Cancer | Melvin Tay Chee Kiang |
| 1520 – 1600 | Afternoon Tea Symposium (sponsored by Pfizer) | |
| 1520 – 1610 | Advances in the Diagnosis and Treatment of ALK-positive NSCLC | Ignatius Ou |
| 1610 – 1720 | Session 4: Locally Advanced Disease (Stage III Tumor Board) | Chairpersons: Tan Wan Ling Yap Swee Peng |
| 1610 – 1620 | N2 Case Presentation | Tan Wei Chong |
| 1620 – 1635 | Surgical Oncology Perspective | Soo Ing Xiang |
| 1635 – 1650 | Radiation Oncology Perspective | Ivan Tham |
| 1650 – 1705 | Medical Oncology Perspective | Ang Mei-Kim |
| 1705 – 1720 | Discussion and Q&A | Ang Mei-Kim, Ivan Tham, Soo Ing Xiang, Tan Wan Ling, Tan Wei Chong, Yap Swee Peng |
Day 2: Saturday, 2 March 2019
| Time | Programme | Speaker/Chairpersons |
|---|---|---|
| 0800 – 0900 | Registration | |
| 0815 – 0900 | Breakfast Symposium sponsored by Roche | Chairperson: Daniel Tan |
| Case Presentation | Han Shuting, Joshua Hoe, Tan Ya Hwee | |
| Panel Discussion | Brendan Pang, Kevin Chua, Ong Boon Hean, Ross Soo, Soon Yu Yang, Toh Chee Keong | |
| 0900 – 1020 | Session 5: Updates in Other Thoracic Cancers | Chairpersons Jens Samol Leong Swan Swan |
| 0900 – 0920 | Mesothelioma – Updates | Raphael Bueno |
| 0920 – 0940 | Thymic Tumours – Updates | Sanjay Popat |
| 0940 – 1000 | Small Cell Lung Cancers / Large Cell NEC – What’s New | Caicun Zhou |
| 1000 – 1020 | Panel Discussion | Caicun Zhou, Jens Samol, Leong Swan Swan, Raphael Bueno, Sanjay Popat |
| 1020 – 1100 | Morning Tea Symposium (sponsored by Astrazeneca) | |
| 1020 – 1110 | Experts Perspective on the Management of EGFRm NSCLC: TKI Standard of Care in 2019 | Sanjay Popat |
| 1110 – 1230 | Session 6: Advanced Stage (I) | Chairpersons: Chin Tan Min Soon Yu Yang |
| 1100 – 1130 | Role of Surgery in Stage IV Disease with Oligometastasis | Harish Mithiran Muthiah |
| 1130 – 1150 | Radiation: Role of Radical RT for Oligomet Disease | Kevin Chua Lee Min |
| 1150 – 1210 | Role of Ablation | Too Chow Wei |
| 1210 – 1230 | Medonco: Oligometastatic Disease – Overview, Definition, Patient Selection for Radical Approaches | Caicun Zhou |
| 1230 – 1330 | Lunch Symposium (sponsored by Astrazeneca) | |
| 1330 – 1430 | Session 7: Advanced (II) | Chairpersons: Gillianne Lai Yvonne Ang |
| 1330 – 1350 | Medonco: Immunology Landscape in Metastatic NSCLC | Marina Garassino |
| 1350 – 1410 | Oncogene-Driven Tumours – Updates | Ignatius Ou |
| 1410 – 1430 | Rationale for Combinatorial Strategies in Advanced NSCLC | Ross Soo |
| 1430 – 1520 | Afternoon Tea Symposium (sponsored by MSD) | Chairperson: Ross Soo |
| 1430 – 1520 | Breaking Frontiers in Advanced NSCLC with Immuno-Oncology | Marina Garassino |
| 1520 – 1640 | Session 8: Palliative / Supportive Care | Chairpersons: Alethea Yee Yong Woon Chai |
| 1520 – 1540 | Palliative Care: Optimal Time to Start Palliative Care | Grace Yang |
| 1540 – 1600 | Radiation: Management of CNS Mets (SRS, WBRT) | Koh Wee Yao |
| 1600 – 1620 | Bronchoscopic / Pleural Interventions for Palliation | Lee Pyng |
| 1620 – 1640 | IO Toxicity | Amit Jain |
| 1635 – 1650 | Best Poster Award | Toh Chee Keong |
| 1650 | Closing Remarks | Daniel Tan |